Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

RA, Zittoun; F, Mandelli; R, Willemze; Witte T, de; B, Labar; L, Resegotti; F, Leoni; E, Damasio; G, Visani; G, Papa

doi:10.1056/nejm199501263320403

Public

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

Shared by NobleBlocks on Jan 1, 1995 • 12:00 AM UTC

Authors:

Zittoun RA

Mandelli F

Willemze R

Abstract

Background Allogeneic or autologous bone marrow transplantation and intensive consolidation chemotherapy are used to treat acute myelogenous leukemia in a first complete remission.Methods After induction treatment with daunorubicin and cytarabine, patients who had a complete remission received a fir...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!